In the clinical setting, Bub3 is overexpressed in multiple cancers, and overexpression of Bub3 is associated with poor survival in patients with adrenocortical carcinoma and oral cancer (31, 32). The gene discussed is BUB3; the disease is lip and oral cavity carcinoma.